Dr Reddys Laboratories (RDY) EBIT (2009 - 2026)
Dr Reddys Laboratories' EBIT came in at $39.97 million for the quarter ended Jun 30, 2026, down 80.4% from $204.19 million a year earlier and down 86.8% from the prior quarter.
Powered by 
Analysis
Dr Reddys Laboratories (RDY) EBIT (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Dr Reddys Laboratories reported EBIT of $806.75 million, up 26.4% year-over-year; for the year ended Mar 31, 2026, it came in at $539 million, down 36.6% from the prior year.
- EBIT carries a five-year compound annual growth rate of 10.2% (years ended Mar 2021 to Mar 2026).
- Going back by year, EBIT was $850.01 million in the year ended Mar 31, 2025 (+4.6%), $813 million in the year ended Mar 31, 2024 (+17.0%), $695 million in the year ended Mar 31, 2023 (+78.7%) and $389 million in the year ended Mar 31, 2022 (+17.2%).
- The figure for the quarter ended Jun 30, 2026 represents the lowest quarterly EBIT since the quarter ended Mar 31, 2025.
- Year-over-year, EBIT increased in 1 of the last six quarters, with an average decline of 17.3%.
- The fastest year-over-year change in EBIT over five years came in the quarter ended Mar 31, 2023 (growth of 949.4%), and the weakest in the quarter ended Mar 31, 2024 (a decline of 98.3%).
- Business Quant data shows RDY's EBIT at $302 million (quarter ended Mar 31, 2026), $264 million (quarter ended Dec 31, 2025) and $200.78 million (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 3.16 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 3.51 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -10.39 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 4.27 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Dr Reddys Laboratories | 10.44 Bn | 9.62 Bn | 396.53 Mn | 39.97 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 39.97 Mn |
| Mar 31, 2026 | 302.00 Mn |
| Dec 31, 2025 | 264.00 Mn |
| Sep 30, 2025 | 200.78 Mn |
| Jun 30, 2025 | 204.19 Mn |
| Mar 31, 2025 | 2.59 Mn |
| Dec 31, 2024 | 221.71 Mn |
| Sep 30, 2024 | 209.55 Mn |
| Jun 30, 2024 | 214.88 Mn |
| Mar 31, 2024 | 3.71 Mn |
| Dec 31, 2023 | 2.64 Mn |
| Sep 30, 2023 | 216.14 Mn |
| Jun 30, 2023 | 215.00 Mn |
| Mar 31, 2023 | 212.00 Mn |
| Dec 31, 2022 | 151.00 Mn |
| Sep 30, 2022 | 200.00 Mn |
| Jun 30, 2022 | 158.37 Mn |
| Mar 31, 2022 | 20.20 Mn |
| Dec 31, 2021 | 75.00 Mn |
| Sep 30, 2021 | 122.00 Mn |
API Access
Dr Reddys Laboratories EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=RDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();